|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 28.84 USD | -9.02% |
|
-12.15% | - |
| 08-24 | Top Premarket Gainers | MT |
| 08-18 | Guggenheim Initiates Scribe Therapeutics at Buy With $50 Price Target | MT |
Evolution of the Average Target: Scribe Therapeutics Inc.
Evolution of the Target Price: Scribe Therapeutics Inc.
Changes in Analyst Recommendations: Scribe Therapeutics Inc.
bf0fb2b.RqNF_xaJe2g-NlTiTETuuS6Zij4kOKsoAknLfFrCDxk.Adt1y0LWPgRfRCezHyO9yXHj1XBFefpuSgyOOjGhXi4k6yyqRLoLJVYBJw~1adfc3688ea29c659c4d50dba5ed3d8f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +94.17% | |||
| +15.76% | |||||
| +9.73% | |||||
| +4.87% | |||||
| +16.02% | |||||
| +39.07% | |||||
| -4.86% | |||||
| +26.83% | |||||
| -0.65% | |||||
| -5.2% | |||||
| Average | +19.58% | |||||
| Weighted average by Cap. | +13.49% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
28.84USD
Average target price
56.00USD
Spread / Average Target
+94.17%
High Price Target
60.00USD
Spread / Highest target
+108.04%
Low Price Target
50.00USD
Spread / Lowest Target
+73.37%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- SCTX Stock
- Consensus Scribe Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
